XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2022
Sep. 30, 2021
Current assets:    
Cash and cash equivalents $ 21,243 $ 138,924
Restricted cash 476 18,000
Trade receivables and contract assets, net of allowances for doubtful accounts of $3909 and $668, respectively 107,719 28,364
Inventories, net 66,401 602
Prepaid expenses and other current assets 38,939 3,129
Total current assets 234,778 189,019
Property and equipment, net 187,492 47,978
Operating lease right-of-use assets, net 29,116 8,358
Goodwill 397,337 51,927
Other intangible assets, net 311,628 24,233
Other assets 7,427 341
Total assets 1,167,778 321,856
Current liabilities:    
Accounts payable 31,352 6,163
Accrued expenses and other liabilities 28,494 8,968
Capex line of credit 0 1,749
Fees invoiced in advance 75,481 26,614
Current portion on long-term operating lease 6,151 1,959
Current portion of long-term debt 4,985 9,656
Total current liabilities 146,463 55,109
Long-term operating leases, net 22,901 6,554
Long-term debt, less current portion, net of debt issuance costs 333,773 154,209
Other liabilities 1,514 512
Deferred tax liabilities, net 49,494 344
Total liabilities 554,145 216,728
Contingencies (Note 15)
Shareholders' equity and noncontrolling interest:    
Common shares, no par value: Authorized 74,000,000 shares; 25,515,791 issued and outstanding at June 30, 2022 and 15,931,485 at September 30, 2021 6,341 3,945
Additional paid-in capital 715,387 112,198
Accumulated deficit (104,646) (11,015)
Accumulated other comprehensive loss (3,306) 0
Total equity attributable to common shareholders 613,776 105,128
Noncontrolling interest (143) 0
Total shareholders' equity and noncontrolling interest 613,633 105,128
Total liabilities and shareholders' equity and noncontrolling interest $ 1,167,778 $ 321,856